AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Age-related Wet Macular Degeneration

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD NCT06718816n/a1 site๐Ÿ“ Beijing Beijing Anlong Biopharmaceutical Co., Ltd. Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration NCT07630649Phase 212 sites๐Ÿ“ Phoenix๐Ÿ“ Bakersfield๐Ÿ“ Fullerton Adverum Biotechnologies, Inc. ยท Tests: Ixo-vec Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants NCT04697095NA2 sites๐Ÿ“ Lyon๐Ÿ“ Lyon Hospices Civils de Lyon ยท Tests: Blood samples A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD) NCT07547228Phase 1, Phase 21 site๐Ÿ“ Singapore Intra-IMMUSG Pte Ltd ยท Tests: PRL3-ZUMAB, Normal Saline (0.9% Sodium Chloride) OCT Angiography in Wet AMD NCT02253030n/a1 site๐Ÿ“ Portland Oregon Health and Science University ยท Tests: Optical Coherence Tomography Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD) NCT07185841Phase 1, Phase 21 site๐Ÿ“ Beijing Fujian Haixi Pharmaceuticals Co., Ltd. ยท Tests: HX9428 tablet Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD) NCT06952452Phase 34 sites๐Ÿ“ San Cristรณbal de La Laguna๐Ÿ“ Barcelona๐Ÿ“ Barcelona Parc de Salut Mar ยท Tests: Bevacizumab, Ranibizumab Ophthalmic Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL NCT06893965NA1 site๐Ÿ“ Toulon Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ยท Tests: Intra ocular pressure Measure Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy NCT07695207Phase 31 site๐Ÿ“ Seoul SANGMYUNG innovation ยท Tests: SMZ1, SMZ1 Placebo A Phase 2 Study of NT-101 Topical in Patients With Wet AMD NCT07811726Phase 23 sites๐Ÿ“ Bonita Springs๐Ÿ“ Tulsa๐Ÿ“ Erie NexThera Co., Ltd. ยท Tests: NT-101 ophthalmic solution, Placebo Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) NCT07482176Phase 379 sites๐Ÿ“ Mesa๐Ÿ“ Phoenix๐Ÿ“ Phoenix Adverum Biotechnologies, Inc. ยท Tests: Ixo-vec, Aflibercept MMP-9 Inhibition for Recalcitrant Wet AMD NCT04504123Phase 21 site๐Ÿ“ Iowa City University of Iowa ยท Tests: Doxycycline Hyclate, Placebo A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD NCT06346600n/a10 sites๐Ÿ“ Boston๐Ÿ“ Katy๐Ÿ“ Norfolk Skyline Therapeutics ยท Tests: SKG0106 AVIGA3 (Cohort 2.0) NCT07255859NA1 site๐Ÿ“ Singapore Tan Tock Seng Hospital ยท Tests: Amsler Grid, AVIGA Study in Human iPSCs-derived RPE Cells Transplantation for Advanced (Late-stage) AMD NCT07418177Phase 1, Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: hiPSC-RPEs 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration NCT05197270Phase 1, Phase 226 sites๐Ÿ“ Phoenix๐Ÿ“ Oxnard๐Ÿ“ Sacramento 4D Molecular Therapeutics ยท Tests: 4D-150 IVT, Aflibercept IVT Stem Cell Ophthalmology Treatment Study II NCT03011541NA4 sites๐Ÿ“ Westport๐Ÿ“ Coral Springs๐Ÿ“ Vienna MD Stem Cells ยท Tests: Arm 1 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration NCT07064759Phase 3126 sites๐Ÿ“ Scottsdale๐Ÿ“ Sun City๐Ÿ“ Tucson 4D Molecular Therapeutics ยท Tests: 4D-150 IVT (3E10 vg/eye), EYLEAยฎ (aflibercept) Injection 2 mg (0.05mL) Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). NCT04663750Phase 342 sites๐Ÿ“ Bonn๐Ÿ“ Hamburg๐Ÿ“ Ludwigshafen King's College Hospital NHS Trust ยท Tests: Pars plana vitrectomy, Intravitreal 2 mg aflibercept will be injected at baseline then monthly for two further doses, tโ€ฆ A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) NCT07496567Phase 2, Phase 371 sites๐Ÿ“ Gilbert๐Ÿ“ Encino๐Ÿ“ Mountain View EyeBiotech Ltd. ยท Tests: Tiespectus, Aflibercept Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration NCT06132035Phase 17 sites๐Ÿ“ Manchester๐Ÿ“ Deerfield Beach๐Ÿ“ Augusta Caregen Co. Ltd. ยท Tests: CG-P5 peptide, Placebo, Aflibercept Injection [Eylea] Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration NCT07587515Phase 1, Phase 27 sites๐Ÿ“ Beverly Hills๐Ÿ“ Modesto๐Ÿ“ Wake Forest Eyconis INC. ยท Tests: EYC-0305 Gene Therapy(FT-003) for Wet AMD NCT06492863Phase 1, Phase 21 site๐Ÿ“ Tianjin Frontera Therapeutics ยท Tests: FT-003 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) NCT07440225Phase 2, Phase 3132 sites๐Ÿ“ Scottsdale๐Ÿ“ Fayetteville๐Ÿ“ Springdale EyeBiotech Ltd. ยท Tests: Tiespectus, Aflibercept Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR) NCT07317934Phase 336 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Beijing Innostellar Biotherapeutics Co.,Ltd ยท Tests: LX102, Aflibercept Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals NCT06875245Phase 41 site๐Ÿ“ Prague Faculty Hospital Kralovske Vinohrady ยท Tests: Faricimab Injection Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration NCT07776522Phase 216 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Jilin City West China Hospital ยท Tests: JWK001, Aflibercept (2.0 mg) Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) NCT05986864Phase 1, Phase 29 sites๐Ÿ“ St. Petersburg๐Ÿ“ Boston๐Ÿ“ Katy Skyline Therapeutics (US) Inc. ยท Tests: SKG0106 A Long-term Follow up Study of EXG102-031 in Participants With wAMD NCT06859515n/a1 site๐Ÿ“ Beijing Guangzhou Jiayin Biotech Ltd ยท Tests: No intervention, only for observational studies Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting NCT05093374Phase 41 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: anti-VEGF agent, anti-VEGF agent
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy